NCT06621875 is a clinical trial in Dynapenia, sponsored by Aynur Ayazzade.

Who is sponsoring NCT06621875?

NCT06621875 is sponsored by Aynur Ayazzade.

What condition does NCT06621875 study?

NCT06621875 studies Dynapenia, Muscle Weakness, Sarcopenia.

Is NCT06621875 still recruiting?

NCT06621875 is currently not yet recruiting. Last updated 16 October 2024.

Last reviewed 2024-10-16 · How we verify

NCT06621875

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect Of The Presence Of Dynapenia On Posture, Spine Muscle Elasticity, Strength And Endurance In Young Adults

Not yet recruiting Last updated 16 October 2024

What this trial tests

trial in Dynapenia in 40 participants. Not yet recruiting.

Timeline

1 November 2024

Primary endpoint
1 March 2025

1 October 2025

Quick facts

Lead sponsor	Aynur Ayazzade
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	40
Start date	1 November 2024
Primary completion	1 March 2025
Estimated completion	1 October 2025

Conditions studied

Dynapenia — all drugs for Dynapenia →
Muscle Weakness — all drugs for Muscle Weakness →
Sarcopenia — all drugs for Sarcopenia →

Sponsor

Aynur Ayazzade

Who can join

Adults 18 to 25, any sex, with Dynapenia or Muscle Weakness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present study was to determine the effect of dynapenia on posture, spinal muscle elasticity, strength and endurance in young adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06621875 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aynur Ayazzade
Last refreshed: 16 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06621875.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing